FI890123A0 - Förfarande för framställning av terapeutiskt verksamma indolylpiperidinderivat - Google Patents

Förfarande för framställning av terapeutiskt verksamma indolylpiperidinderivat

Info

Publication number
FI890123A0
FI890123A0 FI890123A FI890123A FI890123A0 FI 890123 A0 FI890123 A0 FI 890123A0 FI 890123 A FI890123 A FI 890123A FI 890123 A FI890123 A FI 890123A FI 890123 A0 FI890123 A0 FI 890123A0
Authority
FI
Finland
Prior art keywords
therapeutically active
method prepares
indolylpiperidine compounds
indolylpiperidine
compounds
Prior art date
Application number
FI890123A
Other languages
English (en)
Finnish (fi)
Other versions
FI890123A (sv
FI91863C (sv
FI91863B (sv
Inventor
Masaaki Matsuo
Takashi Manabe
Shinji Shigenaga
Hiroshi Matsuda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888800795A external-priority patent/GB8800795D0/en
Priority claimed from GB888818260A external-priority patent/GB8818260D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI890123A0 publication Critical patent/FI890123A0/sv
Publication of FI890123A publication Critical patent/FI890123A/sv
Application granted granted Critical
Publication of FI91863B publication Critical patent/FI91863B/sv
Publication of FI91863C publication Critical patent/FI91863C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI890123A 1988-01-14 1989-01-11 Förfarande för framställning av terapeutiskt verksamma indolylpiperidinderivat FI91863C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8800795 1988-01-14
GB888800795A GB8800795D0 (en) 1988-01-14 1988-01-14 New indolylpiperidine compounds processes for preparations thereof & pharmaceutical composition comprising same
GB8818260 1988-08-01
GB888818260A GB8818260D0 (en) 1988-08-01 1988-08-01 New indolylpiperidine compounds processes for preparation thereof & pharmaceutical composition comprising same

Publications (4)

Publication Number Publication Date
FI890123A0 true FI890123A0 (sv) 1989-01-11
FI890123A FI890123A (sv) 1989-07-15
FI91863B FI91863B (sv) 1994-05-13
FI91863C FI91863C (sv) 1994-08-25

Family

ID=26293316

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890123A FI91863C (sv) 1988-01-14 1989-01-11 Förfarande för framställning av terapeutiskt verksamma indolylpiperidinderivat

Country Status (16)

Country Link
US (2) US4935432A (sv)
EP (1) EP0324431B1 (sv)
JP (1) JPH0759577B2 (sv)
KR (1) KR0130899B1 (sv)
CN (1) CN1021733C (sv)
AU (1) AU620583B2 (sv)
CA (1) CA1336605C (sv)
DE (1) DE68901039D1 (sv)
DK (1) DK733788A (sv)
ES (1) ES2032339T3 (sv)
FI (1) FI91863C (sv)
GR (1) GR3004987T3 (sv)
HU (2) HU202224B (sv)
IE (1) IE63476B1 (sv)
IL (1) IL88903A (sv)
NO (1) NO172539C (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
CZ288897A3 (cs) * 1995-03-20 1998-02-18 Eli Lilly And Company V poloze 5-substituovaný 3-(1,2,3,6-tetrahydropyridin-4-yl)indol a 3-(piperidin-4-yl)indol a farmaceutický prostředek, který je obsahuje
US6458806B1 (en) * 1996-08-15 2002-10-01 Millennium Pharmaceuticals, Inc. Aryl alkenamides derivatives as MCP-1 antagonists
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU5567000A (en) * 1999-06-24 2001-01-09 Toray Industries, Inc. Alpha1b-adrenergic receptor antagonists
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2002072548A2 (en) * 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
JP2006503827A (ja) * 2002-09-06 2006-02-02 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アレルギー性鼻炎治療用薬剤を製造する目的でインドリル誘導体を用いる使用
US7504426B2 (en) 2002-09-06 2009-03-17 Janssen Pharmaceutica N.V. Heterocyclic compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193584B1 (sv) * 1972-07-28 1975-08-08 Roussel Uclaf
GB1425354A (en) * 1973-10-10 1976-02-18 Wyeth John & Brother Ltd Indole derivatives
FR2258843B1 (sv) * 1974-01-30 1977-09-09 Roussel Uclaf
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2349331A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
JPS57188567A (en) * 1981-05-13 1982-11-19 Fujimoto Seiyaku Kk Novel preparation of etomidoline
US4443461A (en) * 1981-09-10 1984-04-17 John Wyeth & Brother Limited N-[2-[[1-[1H-Indolylalkyl- or oxoalkyl]-4-piperidinyl]-amino]-2-oxoethyl]-arylcarboxamide derivatives
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
JPS60142981A (ja) * 1983-12-28 1985-07-29 Yoshitomi Pharmaceut Ind Ltd 3−インド−ルカルボキサミド誘導体
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
HU211485A9 (en) 1995-11-28
US5017703A (en) 1991-05-21
GR3004987T3 (sv) 1993-04-28
DE68901039D1 (de) 1992-04-30
IL88903A0 (en) 1989-08-15
KR0130899B1 (ko) 1998-04-23
KR890011872A (ko) 1989-08-23
FI890123A (sv) 1989-07-15
EP0324431A1 (en) 1989-07-19
ES2032339T3 (es) 1993-02-01
HUT49871A (en) 1989-11-28
NO172539B (no) 1993-04-26
AU620583B2 (en) 1992-02-20
EP0324431B1 (en) 1992-03-25
NO890155D0 (no) 1989-01-13
IL88903A (en) 1993-03-15
NO172539C (no) 1993-08-04
AU2837089A (en) 1989-07-20
JPH01221377A (ja) 1989-09-04
FI91863C (sv) 1994-08-25
US4935432A (en) 1990-06-19
DK733788D0 (da) 1988-12-30
IE63476B1 (en) 1995-04-19
HU202224B (en) 1991-02-28
IE890048L (en) 1989-07-14
CN1035112A (zh) 1989-08-30
CA1336605C (en) 1995-08-08
CN1021733C (zh) 1993-08-04
JPH0759577B2 (ja) 1995-06-28
DK733788A (da) 1989-07-15
NO890155L (no) 1989-07-17
FI91863B (sv) 1994-05-13

Similar Documents

Publication Publication Date Title
FI895531A0 (sv) Förfarande för framställning av farmakologiskt verkande kinuklidiner
DK317889A (da) Sproejtemetode
NO894904L (no) Terapeutisk redskap.
ES2012750A4 (es) Conjunto recipiente-aplicador
NO902853L (no) Elektrode for iontoforese.
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
DK184489A (da) Bicyclodioner
FI890123A (sv) Förfarande för framställning av terapeutiskt verksamma indolylpiperidinderivat
DK532589A (da) Referenceelektrode
FI896361A0 (sv) Fluidumtryckaktuator
DK591189D0 (da) Lamelportfloej
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
FI880190A (sv) Förfarande för framställning av terapeutiskt verksamma tetrahydrofuranderivat
NO902852D0 (no) Elektrode for iontoforese.
FI91488B (sv) Sikt
DE68928064D1 (de) Getterprozess
SE8902170D0 (sv) Therapeutically active compounds
KR890016908U (ko) 꿀벌용 사양기 아미
KR900012326U (ko) 벽체용 구조체
KR890020661U (ko) 도마
DK496689A (da) Naphthalenderivater
SE8800391D0 (sv) Stodben for stegar
DK182488D0 (da) Doseringsmetode
LV5441A3 (lv) Aerosola varstulis

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.